Introduction
Radical radiotherapy (RT) with or without chemotherapy is the primary treatment for patients with locally advanced unresectable or medically inoperable non-small cell lung cancer (NSCLC). Increasing conventional RT dose from 40 -60 Gy and dose intensification with continuous hyperfractionated accelerated radiotherapy (CHART) result in improved local control and survival in patients treated with radical RT 1, 2 . Increasing dose beyond the tolerance limits of normal lung, however, leads to an increased risk of radiation-induced pulmonary toxicity [3] [4] [5] . The addition of sequential or concomitant cisplatin-based chemotherapy to RT improves survival by 4-5% at 2 years. Concomitant treatment, however, is associated with an increased risk of radiation-induced oesophageal toxicity [6] [7] [8] [9] [10] [11] .
The aim of modern RT is to increase dose to the tumour without additional normal tissue toxicity by minimising the dose to normal tissues. When applied to radical RT for NSCLC this principally means avoiding high dose radiation to normal lung. One of the main challenges in reducing normal lung irradiation is respiration induced tumour movement. Conventional NSCLC RT deals with the problem of external patient movement and internal tumour movement by employing wide margins around the clinical target volume (CTV) producing a large planning target volume (PTV) 12 . The CTV-PTV margin encompasses an internal margin (IM) which covers variations in tumour movement and a set-up error margin (SM) for external patient movement 13 . The IM can include a large volume of normal lung limiting the dose that can be delivered to the tumour.
Techniques that reduce both patient and tumour movement facilitate a reduction in the PTV, thereby reducing the volume of normal lung irradiated and potentially allow for dose escalation. Two strategies to compensate for tumour movement have evolved. The first aims to reduce internal respiration induced movement by maintaining a breath-hold, either actively or passively [14] [15] [16] [17] . The second allows the patient to breathe freely with RT delivery either synchronised during a pre-defined phase of the respiratory cycle or continuously delivered while tracking the tumour [18] [19] [20] .
This study addresses the effect of a breath-holding technique using an Active
Breathing Control (ABC) device (The William Beaumont Hospital, USA). While the majority of studies assessing the value of ABC concentrate on the magnitude of benefit in isolation, we evaluated it in the context of the uncertainty of patient movement during a course of RT. We also assessed oesophageal movement with ABC to determine a planning organ at risk volume (PRV) to explore strategies to reduce oesophageal toxicity during concomitant chemo-radiation. This study provides the basis for appropriate margins for lung tumours and organs at risk (OAR) using ABC and estimates the effect on physical lung parameters.
Patients and methods
The studies were approved by the institutional committee for clinical research and the local ethics committee. Eligible patients gave written informed consent.
Patient characteristics
Between February 2002 and October 2004, 30 patients were recruited to two consecutive studies conducted to assess intrafraction and interfraction tumour and oesophageal movement with ABC. Eligible patients had histologically proven NSCLC and were fit enough for radical RT.
14 patients recruited to Study 1 to assess intrafraction tumour movement with ABC had a mean age of 72 years (range 46 -82 years). Patient and tumour characteristics are shown in Table 1 . Two patients were excluded from the analysis as the tumour was poorly visualised fluoroscopically (Patients 3 and 4). Twelve completed radical RT and two received a palliative schedule.
16 patients recruited to Study 2 to assess interfraction tumour movement had a mean age of 70 years (range 52 -83 years). Patient and tumour characteristics are shown in Table 2 . Two patients progressed during treatment (Patients 3 and 5) and two did not tolerate the ABC device and were excluded from further analysis (Patients 8 and 15). In 7 out of the remaining 12 patients, interfraction oesophageal movement was assessed.
The ABC device
The ABC device consisted of a mouthpiece connected to a transducer turbine air flow meter coupled to a balloon valve 14 . A nose clip was used to ensure breathing was only through the mouthpiece. The resting tidal volume and maximum inspiratory volume (MIV) were recorded. The valve was closed at moderate deep inspiration breath hold (mDIBH) set at 75% of MIV. In the training phase mDIBH was initially held for 5 seconds and then increased by 5
second increments up to a maximum of 30 seconds depending on individual tolerance. The patients were coached during this training phase using audio prompting. Normal breathing could be resumed either by operating a hand-
held switch to open the balloon valve or by releasing the mouthpiece. The breathing trace was reset to zero baseline at the end of exhalation.
Intrafraction tumour movement
Patients were positioned supine on the simulator couch as for treatment with the arms raised above the head (Philips Oncology Systems simulator SLS 23). Images were obtained using a digital simulation system (Oncentra SIM 1.3, MDS Nordion). The tumour was visualised fluoroscopically. We were able to measure the maximal tumour movement rather than the detailed spatial density distribution. This gave the worst-case scenario for the margins without breathing control. To obtain an estimate of the effects of the spatial probability distribution, an estimated SD of 1/3 of the peak to peak amplitude (based on seconds. Two further CT scans using ABC were carried out in the middle (ABC2) and final week (ABC3) of a 6 ½ week course of radiotherapy. The same mDIBH gate volume was used for ABC2 and ABC3 as for ABC1.
Co-registration of the CT scans
The ABC2 and ABC3 CT scans were co-registered to the ABC1 CT scan by matching the vertebral bodies at the level of the tumour. The gross tumour volume (GTV) was defined as the primary tumour mass and lymph nodes ≥ 1 cm in diameter. OAR contoured included both lungs as a single organ (excluding the GTV), the spinal cord and the oesophagus from the thoracic inlet to the gastro-oesophageal junction. The GTV and OARs were contoured by the same physician on all scans.
Assessment of interfraction tumour and oesophageal movement
The centre of mass (COM) of the GTV was determined by the treatment planning system using a spherical autoplace function. The standard deviation 
Patient set-up
Patients using the ABC device were immobilised with the arms raised above the head on a lung board designed to support the elbows. Set-up measurements were taken in the 9 patients (Patients 3, 8, 10, 11, 12, 13, 14, from an electronic portal imaging (EPI) device (Elekta iview GT) were compared to a reference image (digitally reconstructed radiograph) and matched to bony anatomy. Orthogonal images were taken on days 1, 2 and 3 and the systematic set-up error was calculated and corrected for off-line.
Thereafter weekly images were taken and assessed using a tolerance of 5 mm. The set-up error in the y direction was measured on both the anterior and lateral EPI with only the anterior field measurements used in this study.
The systematic set-up error (Σ) for the group was defined as the SD of the distribution of the average set-up displacements for each patient and the random error (σ) was the SD of the individual patients set-up displacements averaged over all the patients in the group 21 .
PTV and PRV calculations
The CTV-PTV margin was calculated using 2.5Σ + 0.7σ, where Σ is the total systematic error including set-up and CTV movement and σ is the corresponding total random error 22 . For the purposes of this study the localised GTV was equivalent to the CTV. The systematic variation of the GTV COM with ABC was defined as the SD of the mean tumour movement on ABC2 and ABC3 relative to ABC1 for each patient. The random variation with ABC was defined as the average of the SD for movement of the tumour in each patient. The systematic and random contributions to the margin were combined in quadrature with the systematic and random set-up error in the x, y and z direction to produce a generic non-uniform PTV margin using ABC.
For the purposes of this study, variations in intra-observer tumour delineation
were not determined.
Irradiation of the oesophagus is of importance in relation to the high dose area in proximity to the PTV. The OAR to PRV margin was calculated using 1.3Σ + 0.5σ, where Σ is the systematic set-up error and systematic movement of the oesophagus and σ is the random set-up error and random movement of the oesophagus 23 . The systematic variation of the oesophagus with ABC was defined as the SD of the mean movement of the oesophagus on ABC2 and ABC3 relative to ABC1. The random variation was defined as the average of the SD for movement of the oesophagus in each patient. The systematic and random contributions to the margin were combined in quadrature with the systematic and random set-up error in the x and z direction and then averaged to produce a generic uniform PRV margin using ABC.
Effect of target volume changes with ABC on physical lung parameters
Three treatment plans were generated in 10 patients from Study 2 using the ABC1 CT dataset. All plans were generated using the same beam arrangement, weighting, wedges and dose prescription. In the first plan the GTV-PTV margin was 15 mm in the y direction and 10 mm in the x and z direction as is the standard practice in our institution (standard PTV). In the second plan an isotropic 15 mm margin was applied, except in the y direction in patients 4 and 9, who had tumours near the diaphragm where a 20 mm margin was used (free-breathing PTV). These were compared to a third plan which employed the GTV-PTV margin defined by tumour movement with ABC as described above (ABC PTV). The effect of the change in PTV size with ABC compared to the standard and free-breathing PTV was assessed by comparing the mean lung dose (MLD), volume of lung irradiated to ≥ 20 Gy (V 20 ) and the volume of lung irradiated to ≥ 13 Gy (V 13 ).
Statistical considerations
To assess the tolerability of ABC in lung cancer patients for treatment, we anticipated that 80% of patients would be able to manage a mDIBH of 20 seconds or more. A success rate of < 50% was considered too low for the introduction of the device into routine clinical practice. A minimum of 14 patients were required to exclude an acceptability of < 50%. The quantilequantile plot method was used to confirm the normal assumptions in the intrafraction tumour movement data and Student's t-test used to compare datasets. We determined the distribution of tumour and oesophageal movement using the Kolmogorov-Smirnov test of normality with Lilliefors Significance Correction. Where the distribution was Gaussian, the SD of tumour and oesophageal displacement between ABC2 and ABC3 relative to ABC1 provides a measure of interfraction movement. The effect of PTV size on lung parameters was compared using the Wilcoxon matched paired t-test. .The mean and SD of displacement of the GTV COM on ABC2 and ABC3
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relative to ABC1 are shown in Table 4 . The systematic and random variations of the tumour with ABC is shown in Table 5 . Individual values of displacement of the GTV COM in the superior-inferior direction between ABC3 and ABC1 are shown in Figure 3 . The shift in tumour position was most marked in patients 2 and 9 in the final week of RT due to tumour shrinkage and resolution of distal collapse and consolidation.
Interfraction oesophageal displacement
A total of 504 oesophageal measurements were analysed in 7 patients. The Table 6 along with the systematic and random variation of the oesophagus in the anterior, posterior, left lateral and right lateral direction averaged over all levels.
Set-up error
A total of 156 EPIs were assessed for set-up error in 9 patients treated on the lung board. Table 7 shows the average and SD for set-up error in each patient. The systematic and random set-up error in the x direction was 1.5 mm and 2.4 mm, in the y direction was 1.9 mm and 2.9 mm and in the z direction was 1.9 mm and 2.2 mm respectively. This is representative of set-up error using the lung board in our department.
PTV and PRV calculations
Combining the systematic and random set-up error in quadrature with the systematic and random intrafraction and interfraction tumour variations with ABC results in a PTV margin of 8.0 mm in the x direction, 11.4 mm in the y direction and 9.4 mm in the z direction (Table 8) The relative mean reduction in physical lung parameters that determine lung toxicity was 6-10% with ABC compared to our standard GTV-PTV margin and 18-25% compared to the free-breathing GTV-PTV margin. The magnitude of benefit of ABC on lung parameters may have been underestimated in this study due to the potential differences in tumour size and lung volume seen when patients are CT scanned during a breath-hold compared to CT scanning during tidal free-breathing 15, 16 . Acquiring a CT scan during a breath-hold reduces imaging motion artefact due to respiration resulting in a smaller more defined GTV 15, 16 . It has also been shown that increasing the lung volume with a deep inspiration breath-hold alone results in a median reduction in the V 20 of almost 2% compared to tidal breathing lung volumes 25 . In this study, the standard and free-breathing GTV-PTV margin was applied to patients scanned in breath-hold. If the patients had been scanned during tidal breathing the effect may have been an increase in GTV size, due to motion artefact together with a reduction in total lung volume. Using a constant GTV-PTV margin, an increase in GTV size and reduction in lung volume would result in an increase in the relative volume of lung irradiated to high doses.
The real benefit therefore, of planning treatment with ABC in breath-hold may be greater than that reported here if the standard GTV-PTV margin had been applied to patients scanned while free-breathing.
Conclusion
These studies demonstrate that ABC is tolerated in a large proportion of lung cancer patients and reduces intrafraction and interfraction tumour motion in the absence of lung atelectasis. Incorporation of ABC into 3-D conformal 3-field coplanar treatment would require patients to maintain a 20 second breath-hold up to 6 times daily for treatment. There was no deterioration in patients' ability to maintain a breath-hold in the final week of RT, but requiring them to do this repeatedly on a daily basis has not been assessed. ABC cannot be considered in isolation and should be coupled with attempts to minimise set-up errors to facilitate PTV margin reduction and dose escalation.
Oesophageal movement with ABC can be incorporated into a PRV to explore the possibility of using highly conformal RT to avoid the oesophagus during concomitant chemo-radiation schedules.
The tolerability and reproducibility of ABC and impact on treatment time need to be assessed during daily treatment of NSCLC before routine implementation of reduced PTV margins and potential dose escalation. 
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